Institution · ReProtect (United States)
Most cited papers from ReProtect (United States)
What are the most cited papers from ReProtect (United States)?
The most cited paper from ReProtect (United States) is "Barrier properties of mucus" (Richard A. Cone, 2008), with 1,471 citations. Next come "In Vitro and In Vivo" (580) and "Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota" (571).
Showing 50 of 61 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Barrier properties of mucus Richard A. Cone · Advanced Drug Delivery Reviews | 17 Dec 2008 | 1,471 |
| 2 | In Vitro and In Vivo Sharon L. Hillier, Thomas R. Moench, Robin J. Shattock et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes | 13 Apr 2005 | 580 |
| 3 | Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota D. Elizabeth O’Hanlon, Thomas R. Moench, Richard A. Cone · PLoS ONE | 6 Nov 2013 | 571 |
| 4 | Origins of vaginal acidity: high d/l lactate ratio is consistent with bacteria being the primary source Elizabeth R. Boskey, Richard A. Cone, Kevin J. Whaley et al. · Human Reproduction | Sep 2001 | 508 |
| 5 | In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide D. Elizabeth O’Hanlon, Thomas R. Moench, Richard A. Cone · BMC Infectious Diseases | 19 Jul 2011 | 385 |
| 6 | Acid Production by Vaginal Flora In Vitro Is Consistent with the Rate and Extent of Vaginal Acidification Elizabeth R. Boskey, K. M. Telsch, Kevin J. Whaley et al. · Infection and Immunity | Oct 1999 | 383 |
| 7 | A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes Larry Zeitlin, Stuart S. Olmsted, Thomas R. Moench et al. · Nature Biotechnology | Dec 1998 | 284 |
| 8 | Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women Salim S. Abdool Karim, Barbra A. Richardson, Gita Ramjee et al. · AIDS | 16 Feb 2011 | 234 |
| 9 | Vaginal concentrations of lactic acid potently inactivate HIV Muriel Aldunate, David P. Tyssen, Adam Johnson et al. · Journal of Antimicrobial Chemotherapy | 8 May 2013 | 186 |
| 10 | In Vitro and in Vivo Characterization of a Potential Universal Placebo Designed for Use in Vaginal Microbicide Clinical Trials Deborah Tien, Roger L. Schnaare, Feirong Kang et al. · AIDS Research and Human Retroviruses | Oct 2005 | 180 |
| 11 | SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans Clare F. Price, David P. Tyssen, Secondo Sonza et al. · PLoS ONE | 15 Sep 2011 | 174 |
| 12 | Vaginal microbicides: detecting toxicities in vivothat paradoxically increase pathogen transmission Richard A. Cone, Timothy E. Hoen, XiXi Wong et al. · BMC Infectious Diseases | Jun 2006 | 137 |
| 13 | Vaginal pH measured in vivo: lactobacilli determine pH and lactic acid concentration D. Elizabeth O’Hanlon, Richard A. Come, Thomas R. Moench · BMC Microbiology | 14 Jan 2019 | 125 |
| 14 | Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent Kristen V. Khanna, Kevin J. Whaley, Larry Zeitlin et al. · Journal of Clinical Investigation | 15 Jan 2002 | 118 |
| 15 | IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections Y-Y Wang, A. Kannan, K L Nunn et al. · Mucosal Immunology | 5 Feb 2014 | 115 |
| 16 | Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli D. Elizabeth O’Hanlon, Blair R Lanier, Thomas R. Moench et al. · BMC Infectious Diseases | 19 May 2010 | 112 |
| 17 | Dissolvable Microneedle Patches for the Delivery of Cell-Culture-Derived Influenza Vaccine Antigens Sushma Kommareddy, Barbara C. Baudner, Seajin Oh et al. · Journal of Pharmaceutical Sciences | 20 Dec 2011 | 107 |
| 18 | Using Monoclonal Antibodies to Prevent Mucosal Transmission of Epidemic Infectious Diseases Larry Zeitlin, Richard A. Cone, Kevin J. Whaley · Emerging infectious diseases | Feb 1999 | 94 |
| 19 | Preventing infectious disease with passive immunization Larry Zeitlin, Richard A. Cone, Thomas R. Moench et al. · Microbes and Infection | May 2000 | 93 |
| 20 | Tests of BufferGel for Contraception and Prevention of Sexually Transmitted Diseases in Animal Models Larry Zeitlin, Timothy E. Hoen, Sharon L. Achilles et al. · Sexually Transmitted Diseases | Jul 2001 | 90 |
| 21 | Tests of vaginal microbicides in the mouse genital herpes model Larry Zeitlin, Kevin J. Whaley, Tracy A. Hegarty et al. · Contraception | Nov 1997 | 88 |
| 22 | The rate at which human sperm are immobilized and killed by mild acidity Stuart S. Olmsted, Norman H. Dubin, Richard A. Cone et al. · Fertility and Sterility | Apr 2000 | 79 |
| 23 | Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus Christine E. Henry, Yingying Wang, Qi Yang et al. · Acta Biomaterialia | 16 Jul 2016 | 66 |
| 24 | Contraceptive Efficacy of a Novel Spermicidal Microbicide Used With a Diaphragm Kurt Thomas Barnhart, Michael J. Rosenberg, H. Trent MacKay et al. · Obstetrics and Gynecology | Sep 2007 | 62 |
| 25 | Inhibition ofNeisseria gonorrhoeaeGenital Tract Infection by Leading‐Candidate Topical Microbicides in a Mouse Model Steven E. Spencer, Iris E. Valentin-Bon, Kevin J. Whaley et al. · The Journal of Infectious Diseases | 28 Jan 2004 | 61 |
| 26 | A Self-Sampling Method to Obtain Large Volumes of Undiluted Cervicovaginal Secretions Elizabeth R. Boskey, Thomas R. Moench, Paul S. Hees et al. · Sexually Transmitted Diseases | Feb 2003 | 60 |
| 27 | Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model Stuart S. Olmsted, Kristen V. Khanna, Erina M Ng et al. · BMC Infectious Diseases | 30 Sep 2005 | 55 |
| 28 | Microbicide Efficacy and Toxicity Tests in a Mouse Model for Vaginal Transmission of Chlamydia trachomatis Sharon L. Achilles, Priya B. Shete, Kevin J. Whaley et al. · Sexually Transmitted Diseases | Nov 2002 | 53 |
| 29 | A View from the past into our collective future: the oncofertility consortium vision statement Teresa K. Woodruff et al. · Journal of Assisted Reproduction and Genetics | 2021 | 52 |
| 30 | Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse Thomas R. Moench, Russell J. Mumper, Timothy E. Hoen et al. · BMC Infectious Diseases | 18 Nov 2010 | 52 |
| 31 | Enema ion compositions for enhancing colorectal drug delivery Katharina Maisel, Sumon Chattopadhyay, Thomas R. Moench et al. · Journal of Controlled Release | 2 May 2015 | 47 |
| 32 | Perceptions of Reimbursement for Clinical Trial Participation Carmen Radecki Breitkopf, Melissa L. Loza, Kathleen L. Vincent et al. · Journal of Empirical Research on Human Research Ethics | Sep 2011 | 44 |
| 33 | Topically Applied Human Recombinant Monoclonal IgG1Antibody and Its Fab and F(ab′)2Fragments Protect Mice from Vaginal Transmission of HSV-2 Larry Zeitlin, Kevin J. Whaley, Pietro Paolo Sanna et al. · Virology | Nov 1996 | 43 |
| 34 | Safety and Acceptability of Penile Application of 2 Candidate Topical Microbicides: BufferGel and PRO 2000 Gel Stephen R. Tabet, Marianne M. Callahan, Christine K. Mauck et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes | Aug 2003 | 41 |
| 35 | Pharmacokinetics and Preliminary Safety of Pod-Intravaginal Rings Delivering the Monoclonal Antibody VRC01-N for HIV Prophylaxis in a Macaque Model Chunxia Zhao, Manjula Gunawardana, Francois J. Villinger et al. · Antimicrobial Agents and Chemotherapy | 18 Apr 2017 | 33 |
| 36 | Formulating a Sulfonated Antiviral Dendrimer in a Vaginal Microbicidal Gel Having Dual Mechanisms of Action Russell J. Mumper, Michael A. Bell, David R. Worthen et al. · Drug Development and Industrial Pharmacy | 28 Nov 2008 | 33 |
| 37 | A Phase I study of the functional performance, safety and acceptability of the BufferGel® Duet™ Susan Aucott Ballagh, Vivian Brache, Christine K. Mauck et al. · Contraception | 28 Jan 2008 | 30 |
| 38 | Efficient and facile delivery of gold nanoparticles in vivo using dissolvable microneedles for contrast-enhanced optical coherence tomography Chang Soo Kim, Yeh‐Chan Ahn, Petra B. B. Wilder-Smith et al. · Biomedical Optics Express | 14 Jul 2010 | 29 |
| 39 | An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV‐based vaginal rings Kathleen M. MacQueen, Elizabeth E. Tolley, Derek H. Owen et al. · Journal of the International AIDS Society | Sep 2014 | 28 |
| 40 | Evaluation of Microbicide Gel Adherence Monitoring Methods Thomas R. Moench, D. Elizabeth O’Hanlon, Richard A. Cone · Sexually Transmitted Diseases | Feb 2012 | 26 |
| 41 | Non-Specific Microbicide Product Development: Then and Now Joseph Romano, Melissa Robbiani, Gustavo F. Doncel et al. · Current HIV Research | 2012 | 21 |
| 42 | Appropriateness of Hydroxyethylcellulose Gel as a Placebo Control in Vaginal Microbicide Trials Barbra A. Richardson, Cliff Kelly, Gita Ramjee et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes | 18 Jan 2013 | 21 |
| 43 | Hormonal contraception and the risks of STI acquisition: results of a feasibility study to plan a future randomized trial David Hubacher, Elizabeth Raymond, Mags E. Beksinska et al. · Contraception | 19 Mar 2008 | 21 |
| 44 | An acceptability and safety study of the Duet® cervical barrier and gel delivery system in Zimbabwe Elizabeth T Montgomery, Cynthia Woodsong, Petina Musara et al. · Journal of the International AIDS Society | 2010 | 18 |
| 45 | Biomarkers and biometric measures of adherence to use of ARV‐based vaginal rings Randy M. Stalter, Thomas R. Moench, Kathleen M. MacQueen et al. · Journal of the International AIDS Society | 2016 | 17 |
| 46 | A Pilot Study of Treatment of Bacterial Vaginosis with a Buffering Vaginal Microbicide Joseph Irvin Harwell, Thomas R. Moench, Kenneth Hugh Mayer et al. · Journal of Women s Health | Apr 2003 | 16 |
| 47 | Skin immunisation activates an innate lymphoid cell-monocyte axis regulating CD8+ effector recruitment to mucosal tissues Marija Zaric, Pablo Daniel Becker, Catherine Hervouet et al. · Nature Communications | 17 May 2019 | 15 |
| 48 | Comparison of an anti-HSV-2 monoclonal IgG and its IgA switch variant for topical immunoprotection of the mouse vagina Larry Zeitlin, Philip E. Castle, Kevin J. Whaley et al. · Journal of Reproductive Immunology | Oct 1998 | 12 |
| 49 | Preventing transmission: plant-derived microbicides and mucosal vaccines for reproductive health Kevin J. Whaley, Larry Zeitlin · Vaccine | 15 Dec 2004 | 12 |
| 50 | Cell-Associated Transmission of HIV Type 1 and Other Lentiviruses in Small-Animal Models Thomas R. Moench · The Journal of Infectious Diseases | 20 Nov 2014 | 8 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.